Stereotactic body radiation therapy for oligometastases.

Simon S. Lo, Bin S. Teh, Nina A. Mayr, Thomas E. Olencki, Jian Z. Wang, John C. Grecula, Jiade J. Lu, Robert D. Timmerman

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

There are data in the literature to suggest the presence of an oligometastatic state, and local aggressive therapy of the oligometastases may improve outcomes including survival. Stereotactic body radiation therapy has emerged as one of the local therapy options for oligometastases in various body sites, most commonly in the lung and the liver. Retrospective studies and clinical trials have demonstrated promising results with the use of stereotactic body radiation therapy for oligometastases. However, most of the studies have relatively short follow-up intervals. Longer follow-up is necessary to better define the role of stereotactic body radiation therapy in the management of patients with oligometastases. Given the high propensity for distant progression, the combination of novel systemic therapy and stereotactic body radiation therapy is to be explored.

Original languageEnglish (US)
Pages (from-to)247-254
Number of pages8
JournalDiscovery medicine
Volume10
Issue number52
StatePublished - Sep 2010

Fingerprint

Radiotherapy
Therapeutics
Retrospective Studies
Clinical Trials
Lung
Survival
Liver

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Lo, S. S., Teh, B. S., Mayr, N. A., Olencki, T. E., Wang, J. Z., Grecula, J. C., ... Timmerman, R. D. (2010). Stereotactic body radiation therapy for oligometastases. Discovery medicine, 10(52), 247-254.

Stereotactic body radiation therapy for oligometastases. / Lo, Simon S.; Teh, Bin S.; Mayr, Nina A.; Olencki, Thomas E.; Wang, Jian Z.; Grecula, John C.; Lu, Jiade J.; Timmerman, Robert D.

In: Discovery medicine, Vol. 10, No. 52, 09.2010, p. 247-254.

Research output: Contribution to journalArticle

Lo, SS, Teh, BS, Mayr, NA, Olencki, TE, Wang, JZ, Grecula, JC, Lu, JJ & Timmerman, RD 2010, 'Stereotactic body radiation therapy for oligometastases.', Discovery medicine, vol. 10, no. 52, pp. 247-254.
Lo SS, Teh BS, Mayr NA, Olencki TE, Wang JZ, Grecula JC et al. Stereotactic body radiation therapy for oligometastases. Discovery medicine. 2010 Sep;10(52):247-254.
Lo, Simon S. ; Teh, Bin S. ; Mayr, Nina A. ; Olencki, Thomas E. ; Wang, Jian Z. ; Grecula, John C. ; Lu, Jiade J. ; Timmerman, Robert D. / Stereotactic body radiation therapy for oligometastases. In: Discovery medicine. 2010 ; Vol. 10, No. 52. pp. 247-254.
@article{531b1805839c4df5b599244030614bbf,
title = "Stereotactic body radiation therapy for oligometastases.",
abstract = "There are data in the literature to suggest the presence of an oligometastatic state, and local aggressive therapy of the oligometastases may improve outcomes including survival. Stereotactic body radiation therapy has emerged as one of the local therapy options for oligometastases in various body sites, most commonly in the lung and the liver. Retrospective studies and clinical trials have demonstrated promising results with the use of stereotactic body radiation therapy for oligometastases. However, most of the studies have relatively short follow-up intervals. Longer follow-up is necessary to better define the role of stereotactic body radiation therapy in the management of patients with oligometastases. Given the high propensity for distant progression, the combination of novel systemic therapy and stereotactic body radiation therapy is to be explored.",
author = "Lo, {Simon S.} and Teh, {Bin S.} and Mayr, {Nina A.} and Olencki, {Thomas E.} and Wang, {Jian Z.} and Grecula, {John C.} and Lu, {Jiade J.} and Timmerman, {Robert D.}",
year = "2010",
month = "9",
language = "English (US)",
volume = "10",
pages = "247--254",
journal = "Discovery medicine",
issn = "1539-6509",
publisher = "Discovery Medicine",
number = "52",

}

TY - JOUR

T1 - Stereotactic body radiation therapy for oligometastases.

AU - Lo, Simon S.

AU - Teh, Bin S.

AU - Mayr, Nina A.

AU - Olencki, Thomas E.

AU - Wang, Jian Z.

AU - Grecula, John C.

AU - Lu, Jiade J.

AU - Timmerman, Robert D.

PY - 2010/9

Y1 - 2010/9

N2 - There are data in the literature to suggest the presence of an oligometastatic state, and local aggressive therapy of the oligometastases may improve outcomes including survival. Stereotactic body radiation therapy has emerged as one of the local therapy options for oligometastases in various body sites, most commonly in the lung and the liver. Retrospective studies and clinical trials have demonstrated promising results with the use of stereotactic body radiation therapy for oligometastases. However, most of the studies have relatively short follow-up intervals. Longer follow-up is necessary to better define the role of stereotactic body radiation therapy in the management of patients with oligometastases. Given the high propensity for distant progression, the combination of novel systemic therapy and stereotactic body radiation therapy is to be explored.

AB - There are data in the literature to suggest the presence of an oligometastatic state, and local aggressive therapy of the oligometastases may improve outcomes including survival. Stereotactic body radiation therapy has emerged as one of the local therapy options for oligometastases in various body sites, most commonly in the lung and the liver. Retrospective studies and clinical trials have demonstrated promising results with the use of stereotactic body radiation therapy for oligometastases. However, most of the studies have relatively short follow-up intervals. Longer follow-up is necessary to better define the role of stereotactic body radiation therapy in the management of patients with oligometastases. Given the high propensity for distant progression, the combination of novel systemic therapy and stereotactic body radiation therapy is to be explored.

UR - http://www.scopus.com/inward/record.url?scp=79952200887&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952200887&partnerID=8YFLogxK

M3 - Article

C2 - 20875346

AN - SCOPUS:79952200887

VL - 10

SP - 247

EP - 254

JO - Discovery medicine

JF - Discovery medicine

SN - 1539-6509

IS - 52

ER -